loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Epalrestat, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Epalrestat

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    Also known as: 82159-09-9, Kinedak, Epalrestatum, Epalrestat [inn], Ono 2235, Ono-2235
    Molecular Formula
    C15H13NO3S2
    Molecular Weight
    319.4  g/mol
    InChI Key
    CHNUOJQWGUIOLD-NFZZJPOKSA-N
    FDA UNII
    424DV0807X
    Epalrestat is an orally available, a non-competitive, reversible inhibitor of aldose reductase (AR), with potential antineoplastic, antioxidant, and anti-inflammatory activities. Upon oral administration, epalrestat non-competitively binds to AR, a polyol pathway enzyme that catalyzes reactive oxygen species (ROS)-initiated lipid peroxidation-generated lipid aldehydes and their glutathione conjugates, which have been implicated in the activation of transcription factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) and activator protein-1 (AP-1), which control the transcription of many inflammatory cytokines. Increased inflammatory cytokines and growth factors promote cell proliferation, a primary feature in the tumorigenesis process. AR is overexpressed in several oxidative stress- and inflammation-related conditions, including cancer.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
    2.1.2 InChI
    InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8-
    2.1.3 InChI Key
    CHNUOJQWGUIOLD-NFZZJPOKSA-N
    2.1.4 Canonical SMILES
    CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O
    2.1.5 Isomeric SMILES
    C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    424DV0807X
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 3-carboxymethyl-5-(methyl-3-phenylpropenylidene)rhodanine

    2. Ono 2

    3. Ono 2235

    4. Ono-2

    5. Ono-2235

    2.3.2 Depositor-Supplied Synonyms

    1. 82159-09-9

    2. Kinedak

    3. Epalrestatum

    4. Epalrestat [inn]

    5. Ono 2235

    6. Ono-2235

    7. Ono-2

    8. 2-((z)-5-((e)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic Acid

    9. Aldonil

    10. Aldorin

    11. Tanglin

    12. 2-[(5z)-5-[(e)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic Acid

    13. Chembl56337

    14. 5-((1z,2e)-2-methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic Acid

    15. Chebi:31539

    16. Ono2235

    17. 5-((z,e)-beta-methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic Acid

    18. Mfcd00865484

    19. 424dv0807x

    20. {(5z)-5-[(2e)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic Acid

    21. Epalrestatum [latin]

    22. {5-[(e)-2-methyl-3-phenyl-prop-2-en-(z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic Acid

    23. 2-[(5z)-5-[(2e)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic Acid

    24. Ono 2

    25. Kinedak (tn)

    26. Unii-424dv0807x

    27. Ncgc00164613-01

    28. Epalrestat- Bio-x

    29. 5-[(1z, 2e)-2-methyl-3-phenylpropenylidene]-4-oxo2-thioxo-3-thiazolidineacetic Acid

    30. Epalrestat [mi]

    31. Epalrestat [jan]

    32. Epalrestat (jp17/inn)

    33. Epalrestat [mart.]

    34. 3-thiazolidineacetic Acid, 5-(2-methyl-3-phenyl-2-propenylidene)-4-oxo-2-thioxo-, (e,e)-

    35. Epalrestat [who-dd]

    36. Schembl49049

    37. Mls000806985

    38. Dtxsid1046479

    39. Gtpl11371

    40. Regid_for_cid_1549120

    41. Hms2747m09

    42. Hms3887a17

    43. Zinc1533688

    44. Bbl029067

    45. Bdbm50049730

    46. S2035

    47. Stk337187

    48. Akos000274207

    49. Bcp9000649

    50. Ccg-267693

    51. Db15293

    52. Ncgc00164613-08

    53. Ncgc00164613-12

    54. As-13345

    55. Be164412

    56. Hy-66009

    57. Smr000414799

    58. Bcp0726000053

    59. E0906

    60. Sw219826-1

    61. D01688

    62. Ab00647195_06

    63. 159e099

    64. Q5382029

    65. [5-(2-methyl-3-phenyl-allylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-acetic Acid

    66. 2-(5-(2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic Acid

    67. 5-((z,e)-.beta.-methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic Acid

    68. (5-[(e)-2-methyl-3-phenyl-prop-2-en-(z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl)-acetic Acid 82159-

    69. {(5z)-5-[(2e)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic Acid

    70. 2-[(5z)-5-[(e)-3-phenil-2-methylprop-2-enylidene]-4-oxo-2-thioxo-3-thiazolidinyl]acetic Acid

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 319.4 g/mol
    Molecular Formula C15H13NO3S2
    XLogP33.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count4
    Exact Mass319.03368562 g/mol
    Monoisotopic Mass319.03368562 g/mol
    Topological Polar Surface Area115 Ų
    Heavy Atom Count21
    Formal Charge0
    Complexity519
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count2
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    Post Enquiry
    POST ENQUIRY